David Lugo - Quantitat Pharmacol, GlaxoSmithKline

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 7 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787

David J. Hirst,Paul Bamborough, Niam Al-Mahdi,Davina C. Angell,Heather A. Barnett,Andrew Baxter,Rino A. Bit,Jack A. Brown,Chun-wa Chung,Peter D. Craggs, Robert P. Davis,Emmanuel H. Demont,Alan Ferrie,Laurie J. Gordon, Isobel Harada, Tim C. T. Ho, Ian D. Holyer,Edward Hooper-Greenhill,Katherine L. Jones,Matthew J. Lindon,Cerys Lovatt,David Lugo,Claire Maller, Grant Mcgonagle,Cassie Messenger,Darren J. Mitchell, David D. Pascoe,Vipulkumar K. Patel,Christopher Patten,Darren L. Poole,Rishi R. Shah,Inmaculada Rioja,Kayleigh A. J. Stafford, Daniel Tape,Simon Taylor,Natalie H. Theodoulou,Laura Tomlinson,Ian D. Wall,Christopher R. Wellaway,Gemma White,Rab K. Prinjha,Philip G. Humphreys

JOURNAL OF MEDICINAL CHEMISTRYno. 12 (2024): 10464-10489

Cited0Views0WOSBibtex

GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain

ACS Medicinal Chemistry Lettersno. 6 (2016): 552-557

Cited53Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn